Oxytocin (5 mg Vial) Dosage Protocol
DSIP is a 9-amino-acid neuropeptide first isolated from rabbit cerebral venous blood during electrically induced sleep. It modulates delta-wave sleep and exhibits anti-stress effects. This page covers the 5 mg vial.
⚡ Quickstart Highlights
Dosing & Reconstitution Guide
Route: Subcutaneous | Frequency: Once daily or PRN | Half-life: ~3 minutes (CNS effects persist 1–2 hrs)
Standard Approach (3 mL = 1.67 mg/mL)
Reconstituting with 3 mL bacteriostatic water produces a concentration of 1.67 mg/mL. Volume per dose changes with concentration; mg dose itself does not change between vial sizes.
| Phase / Protocol | Dose | U-100 Units | Volume | Doses per vial |
|---|---|---|---|---|
| Weeks 1–2 (titration) | 100 mcg | 6 units | 0.060 mL | 50 doses |
| Weeks 3–4 | 200 mcg | 12 units | 0.12 mL | 25 doses |
| Weeks 5–6 | 300 mcg | 18 units | 0.18 mL | 16 doses |
| Weeks 7–12 (target) | 500 mcg | 30 units | 0.30 mL | 10 doses |
Reconstitution Steps
- Wipe the vial stopper and BAC water vial with alcohol; let dry.
- Draw 3 mL of bacteriostatic water into a sterile syringe.
- Inject slowly down the inside glass wall of the peptide vial. Do not aim at the powder.
- Gently swirl until fully dissolved. Do not shake.
- Label with reconstitution date. Refrigerate at 2–8°C; use within 30 days.
Supplies Needed
Estimates for an 8-week and 12-week cycle at 200 mcg per dose, pre-bedtime (7 doses/week).
| Item | 8-Week Cycle | 12-Week Cycle |
|---|---|---|
| Oxytocin (5 mg) vials | 3 vials | 4 vials |
| Insulin syringes (U-100) | 56 | 84 |
| Bacteriostatic water (10 mL) | 1 × 10 mL | 2 × 10 mL |
| Alcohol swabs | 1 × 100-pack | 2 × 100-pack |
Protocol Overview
DSIP is dosed pre-bedtime nightly during a cycle. Effects compound — most users report sleep-quality improvement after 1–2 weeks of consistent use rather than acute changes.
Cycles typically run 2–4 weeks for situational insomnia or stress-recovery protocols.
Dosing Protocol
Once daily or PRN dosing:
- Starting (100 mcg): Conservative starting dose.
- Standard (200 mcg): Common research dose.
- Higher (300 mcg): Persistent insomnia protocols.
Cycle structure: 2–4 weeks active, then break. Continuous nightly use is sometimes done; the literature supports cycled approaches better.
Timing: 30–60 min before bedtime in a calm setting. Avoid screens, caffeine, alcohol within 2h of dosing.
Storage Instructions
| State | Temperature | Duration |
|---|---|---|
| Lyophilized | −20°C (−4°F) | Up to 24 months, dry & dark |
| Reconstituted | 2–8°C (35–46°F) | Up to 28 days, protect from light |
Important Notes
How This Works
Oxytocin is synthesized in the supraoptic and paraventricular nuclei of the hypothalamus. It acts peripherally (stimulating uterine contraction and milk ejection) and centrally via limbic and prefrontal projections. Central effects include social bonding, trust enhancement, anxiolysis, and pair-bonding — mediated by high oxytocin receptor density in the amygdala, nucleus accumbens, and prefrontal cortex.
Potential Benefits & Side Effects
Potential Benefits
- Studied for social-cognition and trust enhancement.
- Anxiolytic effects in social-anxiety models.
- Established clinical use in obstetrics (parturition and lactation).
- Pair-bonding and empathy effects in research models.
Side Effect Profile
- Generally well-tolerated.
- Mild injection-site discomfort.
- Nasal irritation (intranasal route).
- Mood lability in some subjects. Caution during pregnancy — affects uterine tone.
Lifestyle Factors
- Subcutaneous or intranasal — intranasal preferred for CNS social-bonding effects.
- Timing matters — dose 15–30 min before target social or therapeutic context.
- Effects last 1–2 hrs; half-life is ~3 min, CNS effects persist longer.
- Rotate subcutaneous injection sites with daily use.
Injection Technique
- Subcutaneous or intranasal. Rotate sub-Q injection sites.
- Once daily or PRN timing is universal — DSIP is short-acting.